Osteolysis Development Around Uncemented Cups With or Without Screw Holes

Sponsor
Sahlgrenska University Hospital, Sweden (Other)
Overall Status
Completed
CT.gov ID
NCT03692351
Collaborator
Zimmer Biomet (Industry)
95
2
270.6

Study Details

Study Description

Brief Summary

In order to investigate the role of acetabular cup screw holes for the transport of osteolysis-inducing particles in a total hip arthroplasty articulation, the investigators compare the amount of bone loss around acetabular cups with and without holes. Bone loss is measured with computed tomography at 7 years and 15 - 18 years of follow-up.

Condition or Disease Intervention/Treatment Phase
  • Device: Uncemented acetabular cup with screw holes
  • Device: Uncemented acetabular cup without screw holes
N/A

Detailed Description

Particles generated by wear and corrosion within an artificial hip articulation can cause biologically mediated bone loss in the surrounding pelvis. Particles can be found within immunologically active cells inside bone lesions. Holes intended for screw fixation in uncemented acetabular cups are believed to be a main route for these particles from the articulation into the pelvic bone. Using pressfit, screws are not always necessary for a successful fixation of an uncemented cup. The investigator's hypothesis is that a pressfit fixated cup without screw holes will display a decreased amount of periacetabular osteolysis compared to a cup with screw holes. Therefore, 95 hips (90 patients) were randomized to receive either pressfit cups without screw holes or the same type of cup with screw holes. The occurence and size of periacetabular osteolysis will be compared between the two groups. In addition, since the patients will have a computed tomography examination at 7 years and between 15 and 18 years the investigator will also analyze development of periacetabular osteolysis over time. The different cups were paired with three different types of femoral stems. Also, articulation wear and cup and stem fixation will be analyzed using radiostereometry.

Study Design

Study Type:
Interventional
Actual Enrollment :
95 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Osteolysis Development Over Time Around Uncemented Titanium Fiber Mesh Cups With or Without Screw Holes
Actual Study Start Date :
Jun 15, 1994
Actual Primary Completion Date :
Dec 31, 2016
Actual Study Completion Date :
Dec 31, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Cup with screw holes

Uncemented Trilogy cup (Zimmer, Warzaw, IN, US), screw fixation (2 or 3 screws)

Device: Uncemented acetabular cup with screw holes

Experimental: Cup without screw holes

Uncemented Trilogy cup (Zimmer, Warzaw, IN, US) without screw holes, press-fit fixation

Device: Uncemented acetabular cup without screw holes

Outcome Measures

Primary Outcome Measures

  1. Periacetabular osteolysis frequency change between 7 and 18 years [Change between 7 to 18 years after surgery]

    Frequency of osteolysis (%) measured with computed tomography

  2. Periacetabular osteolysis size change between 7 and 18 years [Change between 7 to 18 years after surgery]

    Size of periacetabular osteolysis (cm3) masured with computed tomography

Secondary Outcome Measures

  1. Cup fixation (translation) [18 years postoperatively]

    Cup translation (mm/year) measured with radiostereometry, calculated from multiple measurements during the study period

  2. Cup fixation (rotation) [18 years postoperatively]

    Cup rotation (degrees/year) measured with radiostereometry, calculated from multiple measurements during the study period

  3. Polyethylene wear [18 years postoperatively]

    Polyethylene wear (mm/year) measured with radiostereometry, calculated from multiple measurements during the study period

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • primary or secondary osteoarthritis
Exclusion Criteria:
  • Inflammatory osteoarthritis, hip joint infection

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Sahlgrenska University Hospital, Sweden
  • Zimmer Biomet

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Per-Erik Johanson, Researcher, Sahlgrenska University Hospital, Sweden
ClinicalTrials.gov Identifier:
NCT03692351
Other Study ID Numbers:
  • Protesteam_Trilogy
First Posted:
Oct 2, 2018
Last Update Posted:
Oct 2, 2018
Last Verified:
Sep 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Per-Erik Johanson, Researcher, Sahlgrenska University Hospital, Sweden
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 2, 2018